BioCentury | Jul 1, 2013
Finance

2Q Stock Wrap-Up: If it ain't broke

...KV Pharmaceutical Co. ; neuro-inflammatory disorder company Pharmos Corp. ; and bulk pharmaceutical intermediate company Polydex Pharmaceuticals Ltd....
...Co. (OTCQB:KVPHQ), St. Louis, Mo. PeptiDream Inc. (Tokyo:4587), Tokyo, Japan Pharmos Corp. (Pink:PARS), Iselin, N.J. Polydex Pharmaceuticals Ltd....
BioCentury | Apr 15, 2013
Company News

Polydex board of directors update

Polydex Pharmaceuticals Ltd. (POLXF), Scarborough, Ontario Business: Infectious diseases, Agbio/Veterinary/Environmental Appointed: Thomas Ulie, president and CEO of T.R. Ulie & Associates Inc. WIR Staff Infectious...
BioCentury | Aug 11, 2008
Clinical News

Ushercell: Phase III data

...see BioCentury, Feb. 5, 2007). Data were published in The New England Journal of Medicine. Polydex Pharmaceuticals Ltd....
BioCentury | Dec 10, 2007
Clinical News

Ushercell: Phase I started

...African Phase III trial of Ushercell to prevent HIV in women (see BioCentury, Feb. 5). Polydex Pharmaceuticals Ltd....
BioCentury | Feb 5, 2007
Clinical News

Ushercell: Phase III halted

...said the Nigerian trial did not show an increased HIV risk associated with cellulose sulfate. Polydex Pharmaceuticals Ltd....
BioCentury | Sep 25, 2006
Company News

Polydex management update

Polydex Pharmaceuticals Ltd. (POLXF), Toronto, Ontario Business: Genitourinary, Pulmonary, Veterinary Hired: John Luce as CFO, formerly a consultant Promoted: Sharon Wardlaw to COO from CFO and accounting officer WIR Staff...
BioCentury | Jan 30, 2006
Clinical News

Ushercell: Phase II started

...a clinical diagnosis of BV and no other sexually transmitted diseases or reproductive tract infections. Polydex Pharmaceuticals Ltd....
BioCentury | Oct 25, 2004
Clinical News

Ushercell: Started Phase III

...POLXF began a double-blind, placebo-controlled, Nigerian Phase III trial in 2,160 high-risk HIV negative women. Polydex Pharmaceuticals Ltd....
BioCentury | Mar 22, 2004
Clinical News

Ushercell: Phase II started

...do not desire a pregnancy and who are at low risk for sexually transmitted infections. Polydex Pharmaceuticals Ltd....
BioCentury | Mar 25, 2002
Clinical News

Ushercell: Phase I

...see BioCentury, Sept. 24, 2001). Ushercell caused less irritation compared to a spermicide and lubricant. Polydex Pharmaceuticals Ltd....
Items per page:
1 - 10 of 31
BioCentury | Jul 1, 2013
Finance

2Q Stock Wrap-Up: If it ain't broke

...KV Pharmaceutical Co. ; neuro-inflammatory disorder company Pharmos Corp. ; and bulk pharmaceutical intermediate company Polydex Pharmaceuticals Ltd....
...Co. (OTCQB:KVPHQ), St. Louis, Mo. PeptiDream Inc. (Tokyo:4587), Tokyo, Japan Pharmos Corp. (Pink:PARS), Iselin, N.J. Polydex Pharmaceuticals Ltd....
BioCentury | Apr 15, 2013
Company News

Polydex board of directors update

Polydex Pharmaceuticals Ltd. (POLXF), Scarborough, Ontario Business: Infectious diseases, Agbio/Veterinary/Environmental Appointed: Thomas Ulie, president and CEO of T.R. Ulie & Associates Inc. WIR Staff Infectious...
BioCentury | Aug 11, 2008
Clinical News

Ushercell: Phase III data

...see BioCentury, Feb. 5, 2007). Data were published in The New England Journal of Medicine. Polydex Pharmaceuticals Ltd....
BioCentury | Dec 10, 2007
Clinical News

Ushercell: Phase I started

...African Phase III trial of Ushercell to prevent HIV in women (see BioCentury, Feb. 5). Polydex Pharmaceuticals Ltd....
BioCentury | Feb 5, 2007
Clinical News

Ushercell: Phase III halted

...said the Nigerian trial did not show an increased HIV risk associated with cellulose sulfate. Polydex Pharmaceuticals Ltd....
BioCentury | Sep 25, 2006
Company News

Polydex management update

Polydex Pharmaceuticals Ltd. (POLXF), Toronto, Ontario Business: Genitourinary, Pulmonary, Veterinary Hired: John Luce as CFO, formerly a consultant Promoted: Sharon Wardlaw to COO from CFO and accounting officer WIR Staff...
BioCentury | Jan 30, 2006
Clinical News

Ushercell: Phase II started

...a clinical diagnosis of BV and no other sexually transmitted diseases or reproductive tract infections. Polydex Pharmaceuticals Ltd....
BioCentury | Oct 25, 2004
Clinical News

Ushercell: Started Phase III

...POLXF began a double-blind, placebo-controlled, Nigerian Phase III trial in 2,160 high-risk HIV negative women. Polydex Pharmaceuticals Ltd....
BioCentury | Mar 22, 2004
Clinical News

Ushercell: Phase II started

...do not desire a pregnancy and who are at low risk for sexually transmitted infections. Polydex Pharmaceuticals Ltd....
BioCentury | Mar 25, 2002
Clinical News

Ushercell: Phase I

...see BioCentury, Sept. 24, 2001). Ushercell caused less irritation compared to a spermicide and lubricant. Polydex Pharmaceuticals Ltd....
Items per page:
1 - 10 of 31